Brian L. Egleston
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 1%
- Surgery top 1%
- Emergency Medicine top 0.1%
- Molecular Biology top 5%
- Co-authors
- Robert G. UzzoYu‐Ning WongDaniel O. ScharfsteinGregory J. JurkovichAvery B. NathensFrederick P. RivaraDavid S. SalkeverKatherine P. Frey
- Topics
- Renal cell carcinoma treatment (31 papers)BRCA gene mutations in cancer (31 papers)Global Cancer Incidence and Screening (23 papers)
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesJournal of Clinical Oncology
- Partner nations
- United StatesRussiaCanada
In The Last Decade
Brian L. Egleston
227 papers receiving 11.3k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Pulmonary and Respiratory Medicine 2.9k
- Oncology 2.6k
- Surgery 2.6k
- Emergency Medicine 2.2k
- Molecular Biology 2.0k
Countries citing papers authored by Brian L. Egleston
This map shows the geographic impact of Brian L. Egleston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian L. Egleston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian L. Egleston more than expected).
Fields of papers citing papers by Brian L. Egleston
This network shows the impact of papers produced by Brian L. Egleston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian L. Egleston. The network helps show where Brian L. Egleston may publish in the future.
Co-authorship network of co-authors of Brian L. Egleston
This figure shows the co-authorship network connecting the top 25 collaborators of Brian L. Egleston. A scholar is included among the top collaborators of Brian L. Egleston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian L. Egleston. Brian L. Egleston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 53 | |
| 10 | 1 | |
| 11 | 25 | |
| 12 | 75 | |
| 13 | 10 | |
| 14 | 37 | |
| 15 | 36 | |
| 16 | 53 | |
| 17 | 112 | |
| 18 | 39 | |
| 19 | 45 | |
| 20 | Parental availability for the care of sick children. | 50 |
About Brian L. Egleston
Brian L. Egleston is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 243 papers that have together received 11.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (31 papers), BRCA gene mutations in cancer (31 papers) and Global Cancer Incidence and Screening (23 papers). The work is most often cited by research in Emergency Medicine (2.2k citations), Otorhinolaryngology (425 citations) and Oncology (2.6k citations). Brian L. Egleston has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Robert G. Uzzo, Yu‐Ning Wong, Daniel O. Scharfstein, Gregory J. Jurkovich, Avery B. Nathens, Frederick P. Rivara, David S. Salkever, Katherine P. Frey, Ellen J. MacKenzie and Neal J. Meropol. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.